Search - tctmd.com

Displaying 121 - 140 of 194

Sort: Relevancy | Date

Presentation NY Valves 2025

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Presenter: Sammy Elmariah

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

Can We Solve the Durability Issue? Insights Into New Valve Designs

Presenter: Tamim M. Nazif

June 25, 2025

Presentation NY Valves 2025

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Presenter: Mayra Guerrero

June 25, 2025

Presentation NY Valves 2025

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

Presenter: Christine J. Chung

June 25, 2025

Presentation NY Valves 2025

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Presenter: Isaac George

June 25, 2025

Presentation NY Valves 2025

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

CT Reduces In-Hospital Complications in SAVR

Presenter: Liliane Zillner

June 25, 2025

Presentation NY Valves 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Raj Makkar

June 25, 2025

Presentation NY Valves 2025

Perspectives From TAVR UNLOAD

Presenter: Nicolas M. Van Mieghem

June 25, 2025

Presentation NY Valves 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Presenter: Marc R. Dweck

June 25, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

June 25, 2025

Presentation NY Valves 2025

Not Much, We Need Stronger Evidence!

Presenter: Michael J. Mack

June 25, 2025

Presentation NY Valves 2025

Yes, Most Definitely!

Presenter: Philippe Genereux

June 25, 2025

Presentation NY Valves 2025

Temporal Trends in Isolated and Combined Aortic Valve Replacement in Patients Aged <65 Years

Presenter: Tanush Gupta

June 25, 2025

Presentation NY Valves 2025

Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice

Presenter: Patrick T. O'Gara

June 25, 2025

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Anatomy for Tricuspid Interventions: "Live" from the OR

Presenter: Isaac George

June 07, 2024

Advertisement

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Case Resolution

Can We Solve the Durability Issue? Insights Into New Valve Designs

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

CT Reduces In-Hospital Complications in SAVR

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives From TAVR UNLOAD

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

Not Much, We Need Stronger Evidence!

Yes, Most Definitely!

Temporal Trends in Isolated and Combined Aortic Valve Replacement in Patients Aged <65 Years

Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Anatomy for Tricuspid Interventions: "Live" from the OR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content